Lista de obras -

A combined data mining approach for infrequent events: analyzing HIV mutation changes based on treatment history.

artículo científico publicado en 2006

A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes

artículo científico publicado en 2011

Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance

artículo científico publicado en 2004

Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infection

artículo científico publicado en 2009

Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug susceptibility assays

artículo científico publicado en 2005

Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.

artículo científico publicado en 2008

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations

artículo científico publicado en 2010

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

artículo científico publicado en 2015

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

artículo científico publicado en 2009

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape

artículo científico publicado en 2010

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors

artículo científico publicado en 2017

Genetic Variability of HIV-1 for Drug Resistance Assay Development

artículo científico publicado en 2016

Genotypic predictors of human immunodeficiency virus type 1 drug resistance

artículo científico publicado en 2006

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

artículo científico publicado en 2015

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

artículo científico publicado en 2015

HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance

artículo científico publicado en 2005

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation

artículo científico publicado en 2016

HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure

artículo científico publicado en 2013

HIV-1 integrase inhibitor resistance and its clinical implications

artículo científico publicado en 2011

HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes

artículo científico publicado en 2006

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

artículo científico publicado en 2007

HIV-1 subtype B protease and reverse transcriptase amino acid covariation

artículo científico publicado en 2007

HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates

scientific article published on 01 September 2020

Human immunodeficiency virus reverse transcriptase and protease sequence database

artículo científico publicado en 2003

Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors

artículo científico publicado en 2014

Knowledge integration of software for HIV drug resistance research.

artículo científico

Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation

artículo científico publicado en 2003

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors

artículo científico publicado en 2009

Moderate to high levels of pre-treatment HIV drug resistance in KwaZulu-Natal Province, South Africa

article

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1

artículo científico publicado en 2016

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

artículo científico publicado en 2017

Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing

artículo científico publicado en 2013

Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.

artículo científico publicado en 2009

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

artículo científico publicado en 2013

Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations

artículo científico publicado en 2005

Predictive value of HIV-1 genotypic resistance test interpretation algorithms

artículo científico publicado en 2009

Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing

artículo científico publicado en 2017

Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatment

artículo científico publicado en 2007

Protease and Reverse Transcriptase Mutation Patterns in HIV Type 1 Isolates from Heavily Treated Persons: Comparison of Isolates from Northern California with Isolates from Other Regions ⬇️

artículo científico publicado el 1 de octubre de 2003

Response to Therapy in Antiretroviral Therapy-Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor-Associated Transmitted Drug Resistance

artículo científico publicado en 2016

Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay

artículo científico publicado en 2004

Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility ⬇️

artículo científico publicado el 13 de febrero de 2012

Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes

artículo científico publicado en 2012

Super learning: an application to the prediction of HIV-1 drug resistance

artículo científico publicado en 2007

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis

artículo científico publicado en 2016

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

scientific article published on 20 March 2009

Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis

article

Viral population estimation using pyrosequencing

artículo científico publicado en 2008

Virologic efficacy of boosted double versus boosted single protease inhibitor therapy

artículo científico publicado en 2007

Lista de obras de

A combined data mining approach for infrequent events: analyzing HIV mutation changes based on treatment history.

A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes

Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance

Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infection

Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug susceptibility assays

Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors

Genetic Variability of HIV-1 for Drug Resistance Assay Development

Genotypic predictors of human immunodeficiency virus type 1 drug resistance

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation

HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure

HIV-1 integrase inhibitor resistance and its clinical implications

HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

HIV-1 subtype B protease and reverse transcriptase amino acid covariation

HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates

Human immunodeficiency virus reverse transcriptase and protease sequence database

Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors

Knowledge integration of software for HIV drug resistance research.

Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors

Moderate to high levels of pre-treatment HIV drug resistance in KwaZulu-Natal Province, South Africa

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing

Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations

Predictive value of HIV-1 genotypic resistance test interpretation algorithms

Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing

Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatment

Protease and Reverse Transcriptase Mutation Patterns in HIV Type 1 Isolates from Heavily Treated Persons: Comparison of Isolates from Northern California with Isolates from Other Regions ⬇️

Response to Therapy in Antiretroviral Therapy-Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor-Associated Transmitted Drug Resistance

Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay

Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility ⬇️

Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes

Super learning: an application to the prediction of HIV-1 drug resistance

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis

Viral population estimation using pyrosequencing

Virologic efficacy of boosted double versus boosted single protease inhibitor therapy